Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 01:02:24 UTC
Update Date2021-09-26 22:57:48 UTC
HMDB IDHMDB0247886
Secondary Accession NumbersNone
Metabolite Identification
Common NameAcalabrutinib
DescriptionAcalabrutinib belongs to the class of organic compounds known as phenylimidazoles. These are polycyclic aromatic compounds containing a benzene ring linked to an imidazole ring through a CC or CN bond. Based on a literature review a significant number of articles have been published on Acalabrutinib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Acalabrutinib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Acalabrutinib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
SynonymsNot Available
Chemical FormulaC26H23N7O2
Average Molecular Weight465.517
Monoisotopic Molecular Weight465.191323009
IUPAC Name4-{8-amino-3-[1-(but-2-ynoyl)pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl}-N-(pyridin-2-yl)benzamide
Traditional Name4-{8-amino-3-[1-(but-2-ynoyl)pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl}-N-(pyridin-2-yl)benzamide
CAS Registry NumberNot Available
SMILES
CC#CC(=O)N1CCCC1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N1
InChI Identifier
InChI=1S/C26H23N7O2/c1-2-6-21(34)32-15-5-7-19(32)25-31-22(23-24(27)29-14-16-33(23)25)17-9-11-18(12-10-17)26(35)30-20-8-3-4-13-28-20/h3-4,8-14,16,19H,5,7,15H2,1H3,(H2,27,29)(H,28,30,35)
InChI KeyWDENQIQQYWYTPO-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as phenylimidazoles. These are polycyclic aromatic compounds containing a benzene ring linked to an imidazole ring through a CC or CN bond.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassAzoles
Sub ClassImidazoles
Direct ParentPhenylimidazoles
Alternative Parents
Substituents
  • 5-phenylimidazole
  • 4-phenylimidazole
  • Benzamide
  • Imidazo[1,5-a]pyrazine
  • Benzoic acid or derivatives
  • Benzoyl
  • N-acylpyrrolidine
  • Aminopyrazine
  • Monocyclic benzene moiety
  • N-substituted imidazole
  • Imidolactam
  • Pyrazine
  • Pyridine
  • Benzenoid
  • Tertiary carboxylic acid amide
  • Pyrrolidine
  • Heteroaromatic compound
  • Secondary carboxylic acid amide
  • Carboxamide group
  • Amino acid or derivatives
  • Azacycle
  • Carboxylic acid derivative
  • Amine
  • Organonitrogen compound
  • Carbonyl group
  • Hydrocarbon derivative
  • Organic oxide
  • Organic oxygen compound
  • Organooxygen compound
  • Organic nitrogen compound
  • Primary amine
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP2.69ALOGPS
logP2.56ChemAxon
logS-4.6ALOGPS
pKa (Strongest Acidic)12.34ChemAxon
pKa (Strongest Basic)5ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area118.51 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity135.72 m³·mol⁻¹ChemAxon
Polarizability50.86 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+202.42730932474
DeepCCS[M-H]-200.06930932474
DeepCCS[M-2H]-232.95530932474
DeepCCS[M+Na]+208.5230932474

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Predicted by Siyang on May 30, 202211.0938 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20221.76 minutes32390414
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid1725.7 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid164.2 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid136.9 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid144.2 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid88.3 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid331.2 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid483.3 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)173.8 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid759.0 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid142.7 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1394.2 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid256.8 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid294.0 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate197.3 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA186.9 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water80.9 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
AcalabrutinibCC#CC(=O)N1CCCC1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N15668.6Standard polar33892256
AcalabrutinibCC#CC(=O)N1CCCC1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N14712.9Standard non polar33892256
AcalabrutinibCC#CC(=O)N1CCCC1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N14734.2Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Acalabrutinib,1TMS,isomer #1CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)NC3=CC=CC=N3)C=C2)=C2C(N[Si](C)(C)C)=NC=CN124657.6Semi standard non polar33892256
Acalabrutinib,1TMS,isomer #1CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)NC3=CC=CC=N3)C=C2)=C2C(N[Si](C)(C)C)=NC=CN123527.5Standard non polar33892256
Acalabrutinib,1TMS,isomer #1CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)NC3=CC=CC=N3)C=C2)=C2C(N[Si](C)(C)C)=NC=CN126560.5Standard polar33892256
Acalabrutinib,1TMS,isomer #2CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)N(C3=CC=CC=N3)[Si](C)(C)C)C=C2)=C2C(N)=NC=CN124379.9Semi standard non polar33892256
Acalabrutinib,1TMS,isomer #2CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)N(C3=CC=CC=N3)[Si](C)(C)C)C=C2)=C2C(N)=NC=CN123210.0Standard non polar33892256
Acalabrutinib,1TMS,isomer #2CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)N(C3=CC=CC=N3)[Si](C)(C)C)C=C2)=C2C(N)=NC=CN126320.7Standard polar33892256
Acalabrutinib,2TMS,isomer #1CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)N(C3=CC=CC=N3)[Si](C)(C)C)C=C2)=C2C(N[Si](C)(C)C)=NC=CN124373.2Semi standard non polar33892256
Acalabrutinib,2TMS,isomer #1CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)N(C3=CC=CC=N3)[Si](C)(C)C)C=C2)=C2C(N[Si](C)(C)C)=NC=CN123237.3Standard non polar33892256
Acalabrutinib,2TMS,isomer #1CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)N(C3=CC=CC=N3)[Si](C)(C)C)C=C2)=C2C(N[Si](C)(C)C)=NC=CN125925.3Standard polar33892256
Acalabrutinib,2TMS,isomer #2CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)NC3=CC=CC=N3)C=C2)=C2C(N([Si](C)(C)C)[Si](C)(C)C)=NC=CN124528.9Semi standard non polar33892256
Acalabrutinib,2TMS,isomer #2CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)NC3=CC=CC=N3)C=C2)=C2C(N([Si](C)(C)C)[Si](C)(C)C)=NC=CN123468.8Standard non polar33892256
Acalabrutinib,2TMS,isomer #2CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)NC3=CC=CC=N3)C=C2)=C2C(N([Si](C)(C)C)[Si](C)(C)C)=NC=CN126123.8Standard polar33892256
Acalabrutinib,3TMS,isomer #1CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)N(C3=CC=CC=N3)[Si](C)(C)C)C=C2)=C2C(N([Si](C)(C)C)[Si](C)(C)C)=NC=CN124306.0Semi standard non polar33892256
Acalabrutinib,3TMS,isomer #1CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)N(C3=CC=CC=N3)[Si](C)(C)C)C=C2)=C2C(N([Si](C)(C)C)[Si](C)(C)C)=NC=CN123275.2Standard non polar33892256
Acalabrutinib,3TMS,isomer #1CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)N(C3=CC=CC=N3)[Si](C)(C)C)C=C2)=C2C(N([Si](C)(C)C)[Si](C)(C)C)=NC=CN125448.2Standard polar33892256
Acalabrutinib,1TBDMS,isomer #1CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)NC3=CC=CC=N3)C=C2)=C2C(N[Si](C)(C)C(C)(C)C)=NC=CN124823.2Semi standard non polar33892256
Acalabrutinib,1TBDMS,isomer #1CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)NC3=CC=CC=N3)C=C2)=C2C(N[Si](C)(C)C(C)(C)C)=NC=CN123694.4Standard non polar33892256
Acalabrutinib,1TBDMS,isomer #1CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)NC3=CC=CC=N3)C=C2)=C2C(N[Si](C)(C)C(C)(C)C)=NC=CN126500.3Standard polar33892256
Acalabrutinib,1TBDMS,isomer #2CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)N(C3=CC=CC=N3)[Si](C)(C)C(C)(C)C)C=C2)=C2C(N)=NC=CN124568.7Semi standard non polar33892256
Acalabrutinib,1TBDMS,isomer #2CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)N(C3=CC=CC=N3)[Si](C)(C)C(C)(C)C)C=C2)=C2C(N)=NC=CN123392.7Standard non polar33892256
Acalabrutinib,1TBDMS,isomer #2CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)N(C3=CC=CC=N3)[Si](C)(C)C(C)(C)C)C=C2)=C2C(N)=NC=CN126257.2Standard polar33892256
Acalabrutinib,2TBDMS,isomer #1CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)N(C3=CC=CC=N3)[Si](C)(C)C(C)(C)C)C=C2)=C2C(N[Si](C)(C)C(C)(C)C)=NC=CN124686.0Semi standard non polar33892256
Acalabrutinib,2TBDMS,isomer #1CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)N(C3=CC=CC=N3)[Si](C)(C)C(C)(C)C)C=C2)=C2C(N[Si](C)(C)C(C)(C)C)=NC=CN123631.4Standard non polar33892256
Acalabrutinib,2TBDMS,isomer #1CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)N(C3=CC=CC=N3)[Si](C)(C)C(C)(C)C)C=C2)=C2C(N[Si](C)(C)C(C)(C)C)=NC=CN125861.5Standard polar33892256
Acalabrutinib,2TBDMS,isomer #2CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)NC3=CC=CC=N3)C=C2)=C2C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC=CN124888.3Semi standard non polar33892256
Acalabrutinib,2TBDMS,isomer #2CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)NC3=CC=CC=N3)C=C2)=C2C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC=CN123911.4Standard non polar33892256
Acalabrutinib,2TBDMS,isomer #2CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)NC3=CC=CC=N3)C=C2)=C2C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC=CN126012.8Standard polar33892256
Acalabrutinib,3TBDMS,isomer #1CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)N(C3=CC=CC=N3)[Si](C)(C)C(C)(C)C)C=C2)=C2C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC=CN124775.5Semi standard non polar33892256
Acalabrutinib,3TBDMS,isomer #1CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)N(C3=CC=CC=N3)[Si](C)(C)C(C)(C)C)C=C2)=C2C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC=CN123917.6Standard non polar33892256
Acalabrutinib,3TBDMS,isomer #1CC#CC(=O)N1CCCC1C1=NC(C2=CC=C(C(=O)N(C3=CC=CC=N3)[Si](C)(C)C(C)(C)C)C=C2)=C2C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=NC=CN125443.3Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Acalabrutinib GC-MS (Non-derivatized) - 70eV, Positivesplash10-00kr-9628400000-39bb2698cb40f40d9f642021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Acalabrutinib GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Acalabrutinib 10V, Positive-QTOFsplash10-014i-0000900000-49693a6109ef2d7210952021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Acalabrutinib 20V, Positive-QTOFsplash10-014i-0002900000-dfa804fb9d3bb65c89d42021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Acalabrutinib 40V, Positive-QTOFsplash10-001i-4009400000-44f01ac588bf1c452adf2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Acalabrutinib 10V, Negative-QTOFsplash10-03di-0000900000-102133b22290ef2e72b02021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Acalabrutinib 20V, Negative-QTOFsplash10-03di-3037900000-85e6ce8ffaa2231e42e82021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Acalabrutinib 40V, Negative-QTOFsplash10-002f-9035100000-b52b37ea72409c2acef62021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID64870108
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkAcalabrutinib
METLIN IDNot Available
PubChem Compound71226663
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]